B-Cell Neoplasm — Trials

B-Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

7,499 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 101–150 of 3,547 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06534437	MEN1703 (SEL24) to Treat Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma (JASPIS-01)(JASPIS-01)	recruiting	Phase 2	178	Ryvu Therapeutics SAINDUSTRY	4	Sep 18, 2026	clinicaltrials
NCT07210047	Study of HuL001 in Relapsed/Refractory Multiple Myeloma Patients	recruiting	Phase 1 / Phase 2	21	HuniLife Biotechnology, Inc.INDUSTRY	1	Sep 18, 2026	clinicaltrials